Package 63736-200-93

Brand: anacin

Generic: asprin and caffeine
NDC Package

Package Facts

Identity

Package NDC 63736-200-93
Digits Only 6373620093
Product NDC 63736-200
Description

1 BOTTLE in 1 BOX (63736-200-93) / 300 TABLET in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2009-06-25
Brand anacin
Generic asprin and caffeine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4895609d-1ec8-4ebd-8b6e-61ccd452ad5b", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["198479", "211292"], "spl_set_id": ["51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Insight Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 BOX (63736-200-90)  / 100 TABLET in 1 BOTTLE", "package_ndc": "63736-200-90", "marketing_start_date": "20090625"}, {"sample": false, "description": "1 BOTTLE in 1 BOX (63736-200-93)  / 300 TABLET in 1 BOTTLE", "package_ndc": "63736-200-93", "marketing_start_date": "20090625"}], "brand_name": "Anacin", "product_id": "63736-200_4895609d-1ec8-4ebd-8b6e-61ccd452ad5b", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "63736-200", "generic_name": "Asprin and Caffeine", "labeler_name": "Insight Pharmaceuticals LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Anacin", "active_ingredients": [{"name": "ASPIRIN", "strength": "400 mg/1"}, {"name": "CAFFEINE", "strength": "32 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20090625", "listing_expiration_date": "20261231"}